Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Payables (2020 - 2025)

MDxHealth (MDXH) has disclosed Payables for 6 consecutive years, with $10.3 million as the latest value for Q4 2025.

  • Quarterly Payables rose 29.11% to $10.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.3 million through Dec 2025, up 29.11% year-over-year, with the annual reading at $10.3 million for FY2025, 29.11% up from the prior year.
  • Payables hit $10.3 million in Q4 2025 for MDxHealth, up from $8.0 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $10.3 million in Q4 2025 to a low of $7.5 million in Q4 2021.
  • Historically, Payables has averaged $9.0 million across 5 years, with a median of $8.8 million in 2023.
  • Biggest five-year swings in Payables: surged 40.13% in 2021 and later dropped 13.43% in 2023.
  • Year by year, Payables stood at $7.5 million in 2021, then skyrocketed by 36.53% to $10.2 million in 2022, then fell by 13.43% to $8.8 million in 2023, then fell by 9.19% to $8.0 million in 2024, then rose by 29.11% to $10.3 million in 2025.
  • Business Quant data shows Payables for MDXH at $10.3 million in Q4 2025, $8.0 million in Q4 2024, and $8.8 million in Q4 2023.